Arkolith/Insider Trading/GPCR/Form 4

Lin Xichen

CHIEF SCIENTIFIC OFFICERStructure Therapeutics Inc. (GPCR) · full profile →Form 4 · filed Jul 3, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 1, 2025Grant(A)57K—$0217K
Mar 1, 2025Tax withholding(F)6K$7.92$51K160K

Transaction Codes

A
Grant / award
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-019352) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML